库欣综合征的急性危及生命并发症:患病率、预测因素与死亡率
该回顾性队列研究纳入242例库欣综合征患者(良性213例,恶性29例),分析急性并发症的患病率、预测因素及死亡率。结果显示良性垂体、肾上腺、异位库欣综合征急性并发症患病率分别为62%、40%、100%;良性患者中感染25%、血栓栓塞17%、低钾血症13%等。恶性患者并发症发生率更高,观察期死亡率良性2.8%、恶性59%。
要点
- 库欣综合征急性并发症在诊断前和术后均高发。
- 糖化血红蛋白和24小时尿游离皮质醇与急性并发症数量正相关。
- 恶性库欣综合征急性并发症发生率和死亡率显著更高。
核心结论
- 库欣综合征患者急性危及生命并发症患病率高,即使在疾病诊断前和成功手术后仍可发生。
研究设计与样本
- 回顾性队列研究,纳入单中心242例库欣综合征患者,其中良性213例(垂体101例、肾上腺99例、异位13例),恶性29例。
主要发现
- 良性垂体、肾上腺、异位库欣综合征急性并发症患病率分别为62%、40%、100%。
- 良性库欣综合征患者中感染占25%、血栓栓塞事件17%、低钾血症13%、高血压危象9%、心律失常5%、急性冠脉事件3%。
- 23%的良性库欣综合征患者在怀疑库欣综合征前已因急性并发症住院,一半并发症发生于首次手术后。
- 糖化血红蛋白和24小时尿游离皮质醇与每例患者急性并发症数量正相关。
- 观察期死亡率在良性库欣综合征中为2.8%,在恶性库欣综合征中为59%。
临床怎么用
- 临床应警惕库欣综合征患者在诊断前及术后发生急性并发症的风险。
- 对库欣综合征患者需监测糖化血红蛋白和24小时尿游离皮质醇,以评估急性并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Cushing syndrome (CS) results in significant morbidity and mortality. OBJECTIVE: To study acute and life-threatening complications in patients with active CS. METHODS: We performed a retrospective cohort study using inpatient and outpatient records of patients with CS in a tertiary center. A total of 242 patients with CS were included, including 213 with benign CS (pituitary n = 101, adrenal n = 99, ectopic n = 13), and 29 with malignant disease. We collected acute complications necessitating hospitalization, from appearance of first symptoms of hypercortisolism until 1 year after biochemical remission. Mortality data were obtained from the national registry. Baseline factors relating to and predicting acute complications were tested using uni- and multivariate analysis. RESULTS: The prevalence of acute complications was 62% in patients with benign pituitary CS, 40% in patients with benign adrenal CS, and 100% in patients with ectopic CS. Complications observed in patients with benign CS included infections (25%), thromboembolic events (17%), hypokalemia (13%), hypertensive crises (9%), cardiac arrhythmias (5%), and acute coronary events (3%). Among these patients, 23% had already been hospitalized for acute complications before CS was suspected, and half of complications occurred after the first surgery. Glycated hemoglobin (HbA1c) and 24-hour urinary free cortisol positively correlated with the number of acute complications per patient. Patients with malignant disease had significantly higher rates of acute complications. Mortality during the observation period was 2.8% and 59% in benign and malignant CS, respectively. CONCLUSIONS: This analysis highlights the whole spectrum of acute and life-threatening complications in CS, and their high prevalence even before disease diagnosis and after successful surgery.
引用
- Schernthaner-Reiter MH, Siess C, Micko A, et al. Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality. J Clin Endocrinol Metab. 2021. PMID: 33517433. doi:10.1210/clinem/dgab058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。